Jakarta (ANTARA) – Professor of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia (FKUI) Prof. Dr. dr. Junita Indarti said that the low rate of screening conducted by the community has contributed to the high incidence of cervical cancer.
“The high incidence of cervical cancer in Indonesia is affected by the low screening coverage,” he said in a statement in Jakarta, Saturday.
Junita revealed data from the 2021 Indonesia Health Profile, cervical cancer ranks second after breast cancer, namely 36,633 cases or 17.2 percent of all cancers in women.
This number, he said, had a high mortality rate of 21,003 deaths or 19.1 percent of all deaths from cancer.
Until 2021, he continued, only 6.83 percent of women aged 30-50 years would undergo screening tests using the IVA method, while in 2023, cervical cancer screening coverage in Indonesia would only reach 7.02 percent of the target of 70 percent.
“If not handled effectively, cervical cancer rates will increase and cause a large socio-economic burden as well as a decrease in the quality of life of individuals,” he said.
Junita explained that Indonesia’s efforts to accelerate cervical cancer prevention are related to the five pillars of health system transformation which include transformation of primary services, referral services, health financing systems, health human resources (HR), and health technology.
The five pillars, he said, can support two cervical cancer prevention strategies, namely primary prevention by immunizing the Human Papillomavirus (HPV) vaccine and secondary prevention by early detection of cervical cancer.
According to him, screening methods and innovative prevention approaches need to be developed to make them more effective, affordable and easily accessible.
Therefore, he suggested that the government use the HPV DNA test screening method, which has been used in several developed countries because it is more effective in detecting precancerous lesions with a very high sensitivity of HPV DNA testing, which is 80-98 percent, and can be collected through a urine sample. .
“Examination with this urine sample can accommodate patients who have not been screened due to various inhibiting factors,” said Junita.
Considering that cervical cancer has a broad impact, according to Junita, stricter regulations are needed, which require women to have regular check-ups.
“Collaboration between the central and regional governments, hospitals, health centers, professional organizations, and the community is very important for the realization of better health and quality of life for Indonesian women,” said Prof. Dr. dr. Junita Indarti.
Also read: Ministry of Health plans to expand HPV immunization nationally
Also read: Bio Farma produces 3.1 million doses of the Nusagard HPV vaccine
Also read: PAPDI reminds that the HPV vaccine is important to prevent cervical cancer Also read: Cleaning the vagina with a jet spray increases the potential for cervical cancer
2023-08-19 15:12:26
#FKUI #Professor #screening #affects #high #cervical #cancer #ANTARA #News
